Publications

Peer Reviewed Original Research

• Schulz, R.A., W.D. Shlomchik, L. Cherbas, P.T. Cherbas. 1989. Diverse Expression of Overlapping Genes: The Drosophila EIP28/29 Gene and its Upstream Neighbors. .Developmental Biolog. 131:515-523.
• Verma, R.S., D. Giannola, W.D. Shlomchik, S.G. Emerson. 1998. Increased efficiency of liposome-mediated transfection by volume reduction and centrifugation. Biotechniques. 25(1):46-49.
• Shlomchik, W.D., M.S. Couzens, C.B. Tang, J. McNiff, M. Robert, M. Liu, M.J. Shlomchik, S.G. Emerson. 1999. Prevention of Graft-vs.-Host Disease by Inactivation of Host Antigen Presenting Cells. Science. 285:412-415.
• Giannola, D.M., W.D. Shlomchik, M. Jegathesan, D. Liebowitz, T. Kadesch, A. Dancis, S.G. Emerson. 2000. Hematopoietic Expression of HOXB4 is Regulated by USF-1,and USF-2 in Both Leukemic Cell Lines and Normal Hematopoietic Stem Cells. J. Exp. Med. 192:1479-1490.
• Liu, J., B.E. Anderson, M.E. Robert, J.M. McNiff, S.G. Emerson, W.D. Shlomchik, and M.J. Shlomchik. 2001. Selective T-cell subset ablation demonstrates a role for T1 and T2 cells in ongoing acute graft-versus-host disease: a model system for the reversal of disease. Blood. 98(12):3367-3375. (WS and MS were cosenior authors)
• Ruggeri, L. M. Capanni, E. Urbani, K. Perruccio, W.D. Shlomchik, A. Tosti, S. Posati, D. Rogaia, F. Frassoni, F. Aversa, M.F. Martelli and A. Velardi. 2002. Donor alloreactive natural killer cells prevent rejection and graft-versus-host disease, and ablate leukemia in hematopoietic transplantation. Science. 295:2097-2100.
• Zhang, Y., W.D. Shlomchik, G. Joe, J.P. Louboutin, J. Zhu, A. Rivera, D. Giannola, and S.G. Emerson. 2002. APCs in the liver and spleen recruit activated allogeneic CD8(+) T cells to elicit hepatic graft-versus-host disease. Journal of Immunology. 169:7111-7118.
• Anderson, B.E., J. McNiff, J. Yan, H. Doyle, M. Mamula, M.J. Shlomchik, and W.D. Shlomchik. 2003. Memory CD4+ T cells do not induce graft-versus-host disease. J Clin Invest. 112:101-108. (M.S. and W.S. were cosenior authors)
• Matte, C., J. Cormier, B.E. Anderson, I. Athanasiadis, J. Liu, S.G. Emerson, W.S. Pear, W.D. Shlomchik. 2004. Graft-vs.-Leukemia in a Retrovirally Induced Murine CML Model: Mechanisms of T cell Killing. Blood. 103:4353-4361.
• Anderson, B, J. McNiff, C, Matte, I, Athanasiadis, W.D. Shlomchik, and M.J. Shlomchik, M. 2004. Recipient CD4+ T Cells That Survive Irradiation Regulate Chronic Graft-vs.-Host Disease. Blood. 104:1565-1573 (WS and MS were cosenior authors)
• Matte, C., J. Liu, B.E. Anderson, I. Athanasiadis, D. Jain, J. McNiff, and W.D. Shlomchik. 2004. Donor APCs Are Required For Maximal GVHD But Not For GVL. Nat. Med. 10:987-9892.
• Kaplan, D.H., B.E. Anderson, J. McNiff, D. Jain, M.J. Shlomchik and W.D. Shlomchik. 2004. Target Antigens Determine GVHD Phenotype. Journal of Immunology. 173:5467-5475 (WS and MS were cosenior authors)
• Anderson, B., J. McNiff, D, Jain, B.R. Blazar, W.D. Shlomchik, and M.J.Shlomchik. 2005. Distinct Roles for Donor- and Host-derived Antigen Presenting Cells and Costimulatory Molecules in Murine Chronic Graft vs. Host Disease: Requirements Depend on Target Organ . Blood. 105:2227-2234 (WDS and MJS were cosenior authors).
• Kaplan, D.H., et al., Epidermal langerhans cell-deficient mice develop enhanced contact hypersensitivity. Immunity, 2005. 23(6): p. 611-20.

Editorials, Invited Reviews, Book Chapters

• Shlomchik, W.D., Emerson, S.G. The Immunobiology of T Cell Therapies for Leukemias. Acta Haematologica, 1996 Vol. 96, No. 4.
• W.D. Shlomchik; Antigen presentation in graft-vs-host disease. 2004 Exp Hematol 31:1187-1197.
• J. Molldrem and W. D. Shlomchik; Graft versus Leukemia Effects, In Graft-vs.-Host Disease. K. Cooke, H.J. Deeg, and J. Ferrara, editors. Marcel Dekker, Inc., New York. 2005, pp.155-194.